Frontiers in ImmunologyNeurosciencePeer-reviewed journal article
Dual Role of Ninjurin-1 in Myeloid Cell Adhesion and Inflammation in Relapse-Remitting EAE
Coleen E. ThompsoniD, Alex Annett, Anastasia AlkhimovitchiD, Kashish Singh ParihariD, Igal IferganiD
Abstract
Nerve Injury-Induced Protein 1 (Ninjurin-1) is an adhesion molecule implicated in inflammation and tissue injury, yet its role in neuroinflammatory diseases such as multiple sclerosis (MS) remains poorly defined. Here, we identify Ninjurin-1 as a key mediator of immune activation and CNS infiltration in relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE), a model of relapsing-remitting MS (RRMS). Using flow cytometry, gene-expression profiling, and in vivo peptide blockade, we show that Ninjurin-1 is markedly upregulated on CNS-infiltrating myeloid cells during disease progression. Ninjurin-1 myeloid cells display a dual function, as both an adhesion molecule and a marker of inflammatory activation, characterized by increased antigen presentation, cytokine production, and transcriptional enrichment for genes regulating adhesion, migration, and innate immune signaling. Importantly, therapeutic blockade of Ninjurin-1 significantly reduced clinical severity, CNS immune infiltration, and demyelination in RR-EAE. These findings uncover a previously unrecognized role for Ninjurin-1 in myeloid-driven neuroinflammation and highlight its potential as a therapeutic target for relapsing-remitting MS.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 23th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation
H. Horiuchi, B. Parajuli, … H. Takeuchi·bioRxiv·Jul 15, 2020
- CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
D. Hwang, L. L. W. Ishiwaka, … B. Ciric·Proceedings of the National Academy of SciencesPeer-reviewed·Mar 30, 2022
- Increased activity of IRE1 improves the clinical presentation of EAE
Valerie C. Bracchi-Ricard, Kayla Nguyen, … Yair Argon·The FASEB JournalPeer-reviewed·Nov 20, 2023
- Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model
Sadhana Sharma, Sydney J. Risen, … Prashant Nagpal·ACS Chemical NeurosciencePeer-reviewed·Mar 25, 2024
- Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, … Shailendra Giri·bioRxiv·Sep 25, 2023
- Targeting interferon-{lambda} signaling promotes recovery from central nervous system autoimmunity
S. Manivasagam, J. L. Williams, … R. S. Klein·bioRxiv·Aug 17, 2021